OmniSonics Medical Technologies, Inc., a developer of advanced medical devices for use in the treatment of vascular disease, announced that it has enrolled its first patient in the SONIC I Clinical Registry. SONIC I is a prospective, multi-centered U.S. registry study of the company's OmniWave(TM) Endovascular System (OES) in patients undergoing percutaneous mechanical thrombectomy of acute deep vein thrombosis (DVT). All patients enrolled in the SONIC I are scheduled for follow-up at 30 days and 6 months following the OmniWave procedure. The first patient was enrolled by Daniel Clair, M.D., Chairman of Vascular Surgery at The Cleveland Clinic.
full article >> http://www.medicalnewstoday.com/articles/100869.php
Wednesday, March 19, 2008
First Patient Enrolled In SONIC I Registry Of OmniSonics Medical Technologies' OmniWave(TM) Endovascular System
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment